Jazz Pharmaceuticals Plc (JAZZ)

06:03 AM

What MACD and RSI say about Jazz Pharmaceuticals plcShare Buyback & Consistent Growth Equity Picks - newser.com

06:03 AM

03:38 AM

Will Jazz Pharmaceuticals plc stock rally after Fed decisionsRisk Management & Consistent Profit Alerts - newser.com

03:38 AM

03:27 AM

Park Avenue Securities LLC Takes Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

03:27 AM

Sep 30, 2025

Will Jazz Pharmaceuticals plc (J7Z) stock remain on Wall Street radarMarket Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com

Sep 30, 2025

Sep 30, 2025

Will Jazz Pharmaceuticals plc stock keep outperforming rivals2025 Key Highlights & Reliable Price Breakout Signals - newser.com

Sep 30, 2025

Sep 29, 2025

Will Jazz Pharmaceuticals plc (J7Z) stock announce special dividendOptions Play & Real-Time Volume Trigger Notifications - newser.com

Sep 29, 2025

Sep 29, 2025

Is Jazz Pharmaceuticals plc a candidate for recovery playJuly 2025 Rallies & Daily Chart Pattern Signals - newser.com

Sep 29, 2025

Sep 29, 2025

Jazz Pharmaceuticals (JAZZ) Stock Analysis: 47% Potential Upside Catches Investor Attention - DirectorsTalk Interviews

Sep 29, 2025

Sep 29, 2025

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 47% Upside Potential Beckons Investors - DirectorsTalk Interviews

Sep 29, 2025

Sep 29, 2025

State of Alaska Department of Revenue Boosts Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 29, 2025

Sep 29, 2025

Why Jazz Pharmaceuticals plc (J7Z) stock could be top winner2025 Big Picture & AI Forecasted Stock Moves - newser.com

Sep 29, 2025

Sep 29, 2025

What analysts say about Jazz Pharmaceuticals plc stockFederal Reserve Announcements & Small Investment Trading Tips - earlytimes.in

Sep 29, 2025

Sep 28, 2025

Jazz Pharmaceuticals plc J7Z Stock Analysis and ForecastTechnical Resistance Breaks & Low Cost Wealth Plans - earlytimes.in

Sep 28, 2025

Sep 28, 2025

What analysts say about Jazz Pharmaceuticals plc J7Z stockRSI Overbought/Oversold & Free Daily Stock Hotspot Analysis - earlytimes.in

Sep 28, 2025

Sep 27, 2025

Are Jazz Pharmaceuticals Shares Set for a Rebound After Recent Drug Approval in 2025? - simplywall.st

Sep 27, 2025

Sep 27, 2025

Piper Sandler Reaffirms Jazz Pharmaceuticals (JAZZ) Price Target Ahead of Trial Data - MSN

Sep 27, 2025

Sep 26, 2025

What drives Jazz Pharmaceuticals plc stock priceDividend Stock Watch & Exceptional Capital Investment - Early Times

Sep 26, 2025

Sep 26, 2025

Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com

Sep 26, 2025

Sep 26, 2025

EClinical Solutions Explores Data Intelligence in Modern Clinical Trials at ENGAGE 2025 - MarketScreener

Sep 26, 2025

Sep 25, 2025

JAZZ: Morgan Stanley Raises Price Target to $167, Maintains Over - GuruFocus

Sep 25, 2025

Sep 25, 2025

Affinity Wealth Management LLC Purchases New Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 25, 2025

Sep 25, 2025

United States Myelodysplastic Syndrome Treatment Market - openPR.com

Sep 25, 2025

Sep 25, 2025

Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem - MSN

Sep 25, 2025

Sep 24, 2025

Jazz Pharmaceuticals Secures Dismissal of Patent Fraud Lawsuit - Bloomberg Law News

Sep 24, 2025

Sep 24, 2025

Jazz Pharmaceuticals Announces Promising Xywav Data: Why I Assign A BUY Rating - Seeking Alpha

Sep 24, 2025

Sep 24, 2025

Here's Why JAZZ Stock Is an Unconventional Cannabis Investment - The Globe and Mail

Sep 24, 2025

Sep 24, 2025

Morgan Stanley Issues Positive Forecast for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price - MarketBeat

Sep 24, 2025

Sep 24, 2025

Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Perpetual Ltd - MarketBeat

Sep 24, 2025

Sep 24, 2025

Jazz Pharmaceuticals PLC $JAZZ Shares Bought by CX Institutional - MarketBeat

Sep 24, 2025

Sep 23, 2025

Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval - Yahoo Finance

Sep 23, 2025

Sep 23, 2025

Jazz Pharmaceuticals stock price target raised to $167 from $163 at Morgan Stanley - Investing.com UK

Sep 23, 2025

Sep 23, 2025

Jazz Pharmaceuticals (JAZZ): Assessing Valuation Following Fresh Xywav Clinical Data at Leading Medical Conferences - simplywall.st

Sep 23, 2025

Sep 23, 2025

Wedmont Private Capital Decreases Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 23, 2025

Sep 22, 2025

Jazz Pharmaceuticals stock hits 52-week high of $134.24 - MSN

Sep 22, 2025

Sep 22, 2025

Swedbank AB Lowers Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 22, 2025

Sep 22, 2025

Jazz pharma presents new data on narcolepsy and hypersomnia treatment - Investing.com

Sep 22, 2025

Sep 22, 2025

Jazz Pharmaceuticals presents Xywav data at medical conferences - StreetInsider

Sep 22, 2025

Sep 22, 2025

Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses - PR Newswire

Sep 22, 2025

Sep 22, 2025

United States Narcolepsy Therapeutics Market Trends & Growth - openPR.com

Sep 22, 2025

Sep 22, 2025

Voya Investment Management LLC Acquires 22,628 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 22, 2025

Sep 21, 2025

How NCCN Endorsement of Modeyso May Shape Jazz Pharmaceuticals' (JAZZ) Rare Oncology Expansion - simplywall.st

Sep 21, 2025

Sep 21, 2025

Jazz Pharmaceuticals PLC $JAZZ Shares Sold by MassMutual Private Wealth & Trust FSB - MarketBeat

Sep 21, 2025

Sep 21, 2025

Strs Ohio Purchases Shares of 16,445 Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 21, 2025

Sep 20, 2025

Jazz Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo

Sep 20, 2025

Sep 20, 2025

Lingohr Asset Management GmbH Sells 37,288 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 20, 2025